Mounjaro and Zepbound contain tirzepatide, a dual GLP-1/GIP agonist
L leucine modified with an -methyl substituent (MeL, 2-methylleucine)
Stick with what works, be patient as your body adjusts, and work with your healthcare team to monitor your progress
Idaho smaller market meant fewer absolute dollars at stake, but the percentage increases in GLP-1 spending were comparable to larger states
Additionally, GLP-1 receptor activation may influence adipocyte metabolism and lipolysis, though direct effects on adipose tissue remain an area of active investigation
Gallbladder problems: Some patients may develop gallstones or gallbladder inflammation, especially with higher doses, long-term use, or rapid weight loss